Tonghua Dongbao Pharmaceutical Co.,ltd
Clinical trials sponsored by Tonghua Dongbao Pharmaceutical Co.,ltd, explained in plain language.
-
New insulin formula tested for better blood sugar control
Disease control CompletedThis study compared a new insulin injection (THDB0206) against standard insulin therapy in Chinese adults with type 1 diabetes. The goal was to see if the new insulin was as good or better at controlling long-term blood sugar levels over 26 weeks. Participants were already using …
Phase: PHASE3 • Sponsor: Tonghua Dongbao Pharmaceutical Co.,Ltd • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New insulin injection tested in major diabetes trial
Disease control CompletedThis study tested whether a new insulin injection called THDB0206 works as well as a standard insulin combination for controlling blood sugar in people with type 2 diabetes. It involved over 1,000 Chinese adults who were already using insulin. The main goal was to see if the new …
Phase: PHASE3 • Sponsor: Tonghua Dongbao Pharmaceutical Co.,Ltd • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Where you inject insulin matters: study tests different body sites
Knowledge-focused CompletedThis study tested how different injection locations affect how the body absorbs a fast-acting insulin called THDB0206. Researchers gave 27 healthy Chinese adults single insulin injections in different body areas to measure absorption speed and effects on blood sugar. The goal was…
Phase: PHASE1 • Sponsor: Tonghua Dongbao Pharmaceutical Co.,Ltd • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:15 UTC